Skip to main content
. 2023 Jan 13;24(2):1626. doi: 10.3390/ijms24021626
ALT alanine transaminase
AST aspartate transaminase
Bcl-2 B cell lymphoma-2
BCG bacillus calmette-guerin
BUN blood urea nitrogen
Cdc42 Cell division cycle 42
CYP cytochrome
CSB Corydalis saxicola Bunting
CSBI Corydalis saxicola Bunting injection
CSBTA Corydalis saxicola Bunting total alkaloids
CCl4 carbontetrachloride
CD86 cluster of differentiation 86
COX-2 cyclooxygenase-2
DA dopamine
DPPH 2,2-diphenyl-1-picrylhydrazyl
DBiL direct bilirubin
DB direct bilirubin
DHBV duck hepatitis B virus
DOPAC 3,4-Dihydroxyphenylacetic acid
EC50 concentration for 50% of maximal effect
FasL Fas ligand
HT hydroxytryptamine
HIAA hydroxyindolacetic acid
HBV hepatitis B virus
HBsAg hepatitis B surface antigen
HBeAg hepatitis B e antigen
hTERT telomerase reverse transcriptase
HVA homovanillic acid
GT glutamyltransferase
i.p intraperitoneally injected
iNOS inducible nitric oxide synthase
IC50 half maximal inhibitory concentration
IFN-γ interferon-γ
IL interleukin
IENF intraepidermal nerve fiber
Ki inhibition constant
LD50 median lethal dose
LDH lactate dehydrogenase
MDA malondialdehyde
MAPKs mitogen-activated protein kinases
MMP matrix metal loprotease
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
MIC minimal inhibitory concentration
NPN non-protein nitrogen
NF-κB nuclear transcription factor-κB
NMR nuclear magnetic resonance
NFATc1 nuclear factor of activated T-cells c1
OPG osteoprotegerin
QOL quality of life
RANKL receptor activator of nuclear factor- κB ligand
SOD superoxide dismutase
SGPT serum glutamate pyruvate transaminase
SB serum total bilirubin
TNF-α tumour necrosis factor-α
TCA tricarboxylic acid
TGF-β1 transforming growth factor-β1
TBIL totalbilirubin
THP-1 leukemia
TRPV1 transient receptor potential vanilloid 1
TBiL total bilirubin
TACE hepatic artery chemoembolization